Jane Street
AIM

Jane Street’s AIM ImmunoTech AIM Stock Holding History

Jane Street’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7K Buy
+20,047
New +$20.3K ﹤0.01% 11288
2024
Q1 		– Sell
-213
Closed -$9.35K – 10472
2023
Q4 		$9.35K Buy
213
+76
+55% +$3.54K ﹤0.01% 8969
2023
Q3 		$6.23K Sell
137
-85
-38% -$5.24K ﹤0.01% 8428
2023
Q2 		$14.8K Buy
+222
New +$10.7K ﹤0.01% 8391
2022
Q3 		– Sell
-104
Closed -$8K – 11015
2022
Q2 		$8K Buy
+104
New +$9.98K ﹤0.01% 9363
2022
Q1 		– Sell
-155
Closed -$14K – 11590
2021
Q4 		$14K Buy
+155
New +$24K ﹤0.01% 9869
2020
Q2 		– Sell
-281
Closed -$72K – 7887
2020
Q1 		$72K Buy
+281
New +$44.1K ﹤0.01% 5028

Other funds holding AIM

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Jane Street's AIM Position: Q1 2026 in Review

Jane Street opened a new position in AIM ImmunoTech (AIM) in Q1 2026: 20,047 shares worth $11.7K. The stake represents ﹤0.01% of the portfolio and ranks #11288 among its holdings. This is a return to the name: Jane Street previously reported a position in AIM as recently as Q4 2023.

Jane Street first reported a position in AIM in Q1 2020 and has held it in 7 quarters since. The position peaked at $72K in Q1 2020. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

  • Jane Street held 20,047 shares of AIM ImmunoTech worth $11.7K as of Q1 2026.
  • AIM ImmunoTech was a new Jane Street position in Q1 2026.
  • AIM ImmunoTech made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11288 holding.
  • Jane Street first reported a position in AIM ImmunoTech in Q1 2020 and has held it in 7 quarters since.
  • Jane Street's AIM ImmunoTech position peaked at $72K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.